我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

CA125与心力衰竭的研究进展

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2013年第6期
页码:
731-734
栏目:
综述
出版日期:
2013-11-25

文章信息/Info

Title:
CA125 and heart failure: an update
作者:
黄樱硕 综述; 王翠英 审校
（首都医科大学附属北京友谊医院医疗保健中心，北京 100050）
Author(s):
HUANG Ying shuo;  WANG Cui ying
(Medical and Health Center, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China)
关键词:
心力衰竭; 糖抗原125; 肿瘤标志物; 炎症
Keywords:
heart failure;  carbohydrate antigen125;  tumor markers;  inflammation
分类号:
R541.61
DOI:
-
文献标识码:
A
摘要:
肿瘤标志物通常用于筛查、诊断和区分恶性疾病，但是特定的肿瘤标志物可能用于指示心力衰竭（HF）患者。在所有肿瘤标志物中，糖抗原125（CA125）是HF潜在的生化标志物，其与炎症因子、脑钠尿肽（BNP）的水平均呈显著相关。已有研究证明，CA125与HF患者的临床、血流动力学和超声心动图参数相关，能够提示HF的严重程度和预后，并且有助于评价治疗干预措施的效果。本文综述了近年来关于CA125和HF衰患者的研究进展。
Abstract:
Tumor biomarkers are used for screening, diagnosis and stratification of malignant diseases, but the role of some specific tumor markers has also been recently explored in patients with heart failure (HF). Of all the tumor biomarkers, carbohydrate antigen125 (CA125) has emerged as a potential biomarker in HF due to its significant correlation with cytokines and brain natriuretic peptide (BNP) level. It has been demonstrated that CA125 is associated with clinical, hemodynamic and echocardiographic parameters indicative of the severity and therapeutic interventional effect of the disease. This article reviews research progress and clinical use of the tumor marker CA125 in patients with chronic HF.

参考文献/References

[1]Hung CL,Hung TC,Liu CC,et al.Relation of carbohydrate antigen125 to left atrial remodeling and its prognostic usefulness in patients with heart failure and preserved left ventricular ejection fraction in women[J].Am J Cardiol,2012,110(7):993-1000.
[2]Mansour IN,Napan S,Tarek Alahdab M,et al.Carbohydrate antigen 125 predicts longterm mortality in African American patients with acute decompensated heart failure[J].Congest Heart Fail,2010,16(1):15-20.
[3]Vizzardi E,Nodari S,D’Aloia A,et al.CA 125 tumoral marker plasma levels relate to systolic and diastolic ventricular function and to the clinical status of patients with chronic heart failure[J]. Echocardiography,2008,25(9):955-960.
[4]Vizzardi E,D’Aloia A,Pezzali N,et al.Longterm prognostic value of CA 125 serum levels in mild to moderate heart failure patients[J].J Card Fail, 2012,18(1):68-73.
[5]Ordu S,Ozhan H,Alemdar R,et al.Carbohydrate antigen125 and Nterminal probrain natriuretic peptide levels:compared in heartfailure prognostication[J].Tex Heart Inst J,2012,39(1):30-35.
[6]AntoniniCanterin F,Popescu BA,Popescu AC,et al.Heart failure in patients with aortic stenosis: Clinical and prognostic significance of carbohydrate antigen 125 and brain natriuretic peptide measurement[J].Int J Cardiol,2008,128(3):406-412.
[7]Yilmaz MB,Zorlu A,Dogan OT,et al.Role of CA125 in identification of right ventricular failure in chronic obstructive pulmonary disease[J].Clin Cardiol,2011,34(4):244-248.
[8]Yilmaz MB,Zorlu A,Tandogan I.Plasma CA 125 level is related to both sides of the heart:a retrospective analysis[J].Int J Cardiol,2011,149(1):80-82.
[9]Trojnarska O,Gwizdala A,Katarzynski S,et al.Evaluation of exercise capacity with cardiopulmonary exercise testing and BNP levels in adult patients with single or systemic right ventricles[J].Arch Med Sci,2010,6(2):192-197.
[10]Banach M,Rysz J.Current problems in hypertension and nephrology[J].Expert Opin Pharmacother,2010,11(16):2575-2578.
[11]Colombo PC,Ganda A,Lin J,et al.Inflammatory activation:cardiac,renal,and cardiorenal interactions in patients with the cardiorenal syndrome[J].Heart Fail Rev,2012,17(2):177-190.
[12]Huang F,Chen J,Liu Y,et al.New mechanism of elevated CA125 in heart failure:The mechanical stress and inflammatory stimuli initiate CA125 synthesis[J].Medical Hypotheses,2012(79):381-383.
[13]De Gennaro L,Brunetti ND,Montrone D,et al.Inflammatory activation and carbohydrate antigen125 levels in subjects with atrial fibrillation[J].Eur J Clin Invest,2012,42(4):371-375.
[14]Nú?ez J,Sanchis J,Nú?ez E,et al.Benefits of statin therapy based on plasma carbohydrate antigen 125 values following an admission for acute heart failure[J].Rev Esp Cardiol,2011,64(12):1100-1108.
[15]Nú?ez J,Nú?ez E, Consuegra L,et al.Carbohydrate antigen 125:an emerging prognostic risk factor in acute heart failure?[J].Heart,2007,93(6):716-721.
[16]Turgut O,Tandogan I,Yilmaz MB,et al.CA125 levels among patients with advanced heart failure: an emerging independent predictor for survival［J］. Int J Cardiol,2009,145(1):71.
[17]Mi?ana G,Nú?ez J,Sanchis J,et al.CA125 and immunoinflammatory activity in acute heart failure?Int J Cardiol,2010,145(3):547-548.
[18]Nú?ez J,Nú?ez E,Sanchis J,et al.Antigen carbohydrate 125 and brain natriuretic peptide serial measurements for risk stratification following an episode of acute heart failure?Int J Cardiol,2012,159(1):21-28.
[19]De Gennaro L,Brunetti ND,Bungaro R,et al.Carbohydrate antigen 125:additional accuracy in identifying patients at risk of acute heart failure in acute coronary syndrome?Coron Artery Dis, 2009,20(4):274-280.

备注/Memo

备注/Memo:
收稿日期：2013-02-23.通讯作者：王翠英，副主任医师，主要从事老年心血管病研究 Email：wangcuiying823@sina.com 作者简介：黄樱硕，主治医师，博士 Email：huangyingshuo1982@163.com
更新日期/Last Update: 2013-11-20